If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
30
Followers on Owler
Overview
Competitors
Funding
News & Insights
Innate Pharma Funding History
Since Innate Pharma was founded in 1999, it has participated in 7 rounds of funding. In total Innate Pharma has raised $191.0M. Innate Pharma's last funding round was on Apr 2025 for a total of $17.2M.
Innate Pharma Funding Rounds
Unlock 4 more funding rounds →
ROUND
FUNDING DATE
AMOUNT
NUMBER OF INVESTORS
INVESTORS
Post-IPO Equity
Apr 2025
$17.2M
1
Sanofi
Post-IPO Debt
Jan 2022
$32.4M
2
Société Générale
,
BNP Paribas
Grant
Aug 2020
$2M
1
Bpifrance
Corporate Round
Oct 2018
$71.9M
1
AstraZeneca
Private Placement
Nov 2013
$27.4M
__
Innate Pharma Investors
Unlock 2 more investors →
INVESTOR
ROUND
FUNDING DATE
Sanofi
Post-IPO Equity
Apr 2025
Société Générale
Post-IPO Debt
Jan 2022
BNP Paribas
Post-IPO Debt
Jan 2022
Bpifrance
Grant
Aug 2020
AstraZeneca
Corporate Round
Oct 2018
Innate Pharma has 5 investors, including Sanofi, Société Générale and BNP Paribas. The latest investment occurred in Apr 2025.
